Accelerated Access Review (AAR) – a review of adaptive pathways (workstream 2)
What the buyer wrote
On 20 November 2014, the Minister for Life Sciences announced the Accelerated Access Review (AAR). The Review will help to ensure that NHS patients benefit from earlier access to innovative medicines, diagnostics and devices, and help Government lead the global race for life sciences investment by making the UK the best place for 21st century medical innovation and product development. There are direct links to the DH Departmental priority to raise standards in health and care through the use of technology and the Review will support NHS England’s Five Year Forward View commitment to accelerating the quicker adoption of cost-effective medicines, diagnostics and devices. The AAR team are l…
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- Accelerated Access Review (AAR) – a review of adaptive pathways (workstream 2)
- How they are buying
- The buyer did not say
- Type
- services
- Suitable for small firms
- The buyer says yes. What that is worth
- Work starts
- 6 Sep 2015
- Work ends
- 30 Nov 2015
Who the buyer named
Sanjay Chana was the named contact on this notice.